SCHEMBL372980

SCHEMBL372980

C=C(C)C(=O)O[C@H]1CC[C@H](OC(=O)C(=C)C)CC1

nearest known ligand 0.46

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
THRB P10828 1/20 0.39
TSHR P16473 3/20 0.37
TDP1 Q9NUW8 2/20 0.33
EPHX1 P07099 2/20 0.32
SERPINE1 P05121 1/20 0.32
HSD17B10 Q99714 1/20 0.31
NAAA Q02083 1/20 0.31
GPR35 Q9HC97 1/20 0.30
KMT2A Q03164 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL342182 1.00 ALDH1A1 (0.46) ALDH1A1THRBTSHRTDP1EPHX1
SCHEMBL25278 1.00
SCHEMBL91312 0.93 ALDH1A1 (0.41) ALDH1A1THRBTSHRTDP1HSD17B10
SCHEMBL9972479 0.93 ALDH1A1 (0.41) ALDH1A1THRBTSHR
SCHEMBL149225 0.91 ALDH1A1 (0.39) ALDH1A1THRBTSHREPHX1KMT2A
SCHEMBL91313 0.91 ALDH1A1 (0.40) ALDH1A1THRBTSHR
SCHEMBL6674567 0.91 ALDH1A1 (0.39) ALDH1A1THRBTSHR
SCHEMBL2769160 0.91 ALDH1A1 (0.40) ALDH1A1THRBTSHR
SCHEMBL201767 0.91 EPHX1 (0.42) ALDH1A1TSHREPHX1NAAAGPR35
SCHEMBL10645478 0.91 EPHX1 (0.42) ALDH1A1TSHREPHX1NAAAGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9725528-B2 Process of controlled radical polymerization of branched polyacrylates Henkel IP & Holding GmbH (DE) 2017-08-08 US claimed
EP-2935348-A1 PROCESS OF CONTROLLED RADICAL POLYMERIZATION OF BRANCHED POLYACRYLATES Henkel IP & Holding GmbH (DE) 2015-10-28 EP claimed
US-20150274851-A1 PROCESS OF CONTROLLED RADICAL POLYMERIZATION OF BRANCHED POLYACRYLATES HENKEL CORPORATION 2015-10-01 US claimed
US-8912252-B2 Film-forming pigments and coating system including the same SILBERLINE MANUFACTURING COMPANY, INC. (US) 2014-12-16 US claimed
WO-2014099748-A1 PROCESS OF CONTROLLED RADICAL POLYMERIZATION OF BRANCHED POLYACRYLATES Henkel US IP LLC (US) 2014-06-26 WO claimed
EP-1747059-A1 PERVAPORATION COMPOSITE MEMBRANES McMaster University (CA) 2007-01-31 EP claimed
US-20060000778-A1 high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers MCMASTER UNIVERSITY (CA) 2006-01-05 US claimed
WO-2005102503-A1 PERVAPORATION COMPOSITE MEMBRANES MCMASTER UNIVERSITY (CA) 2005-11-03 WO claimed
WO-2026099181-A1 DEVICE CAPABLE OF STAIN-FREE DEBONDING ON DEMAND TESA SE (DE) 2026-05-15 WO disclosed
EP-4737529-A1 ADHESIVE COMPOSITION, ADHESIVE TAPE AND THE USE THEREOF, AND METHOD FOR ELECTRICALLY MODIFYING THE ADHESIVE STRENGTH OF THE ADHESIVE TAPE TESA SE (DE) 2026-05-06 EP disclosed
US-12544482-B2 Antipathogenic compositions SERVICO GROUP OY (FI) 2026-02-10 US disclosed
US-12338397-B2 Materials for separating mixtures via selective absorption UNIVERSITY OF KANSAS (US) 2025-06-24 US disclosed
WO-2025068404-A1 PRESSURE SENSITIVE ADHESIVE ELECTROLYTE TESA SE (DE) 2025-04-03 WO disclosed
EP-4531158-A1 PRESSURE SENSITIVE ADHESIVE ELECTROLYTE TESA SE (DE) 2025-04-02 EP disclosed
EP-2226192-A1 Drying substances, preparation and use thereof Oridion Medical 1987 Ltd. (IL) 2010-09-08 EP disclosed
EP-2226116-A2 Drying substances, preparation and use thereof Oridion Medical 1987 Ltd. (IL) 2010-09-08 EP disclosed
US-7604746-B2 high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers MCMASTER UNIVERSITY (CA) 2009-10-20 US disclosed
EP-1747059-A1 PERVAPORATION COMPOSITE MEMBRANES McMaster University (CA) 2007-01-31 EP disclosed
US-20060000778-A1 high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers MCMASTER UNIVERSITY (CA) 2006-01-05 US disclosed
WO-2005102503-A1 PERVAPORATION COMPOSITE MEMBRANES MCMASTER UNIVERSITY (CA) 2005-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12544482-B2 Antipathogenic compositions PGD, EBP, ACMSD ALDH1A1 470/4885THRB 444/4885TSHR 2588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.